EligibleTrials

A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients

Recruiting · NCT07322367 · Interventional (participants receive a specific treatment) · Lead sponsor: Wake Forest University Health Sciences

View the official record on ClinicalTrials.gov →
Lung Cancer

Interventions studied

Portal Message with Reminder Text MessagesPortal message onlyText Message with Reminder Text MessagesUsual Care

What this trial is about

To evaluate the real-world effectiveness and implementation strategies for mPATH-Lung, investigators propose a pragmatic, randomized controlled trial across an academic Learning Health System. The trial will contrast several approaches to participant outreach and will specifically target engaging fully powered cohorts of racial/ethnic minorities and rural residents.

Who can take part

Age range
50 Years to 77 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.